|
||||
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
||||
|
|
|||
1. Identity of the issuer or the underlying issuer |
Deltex Medical Group plc
|
|||
2 Reason for the notification (please tick the appropriate box or boxes): |
||||
An acquisition or disposal of voting rights |
X |
|||
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached |
|
|||
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments |
|
|||
An event changing the breakdown of voting rights |
|
|||
Other (please specify): |
|
|
||
3. Full name of person(s) subject to the |
Gartmore Investment Limited |
|||
4. Full name of shareholder(s) |
See attached schedule |
|||
5. Date of the transaction and date on |
22nd March 2010 |
|||
6. Date on which issuer notified: |
23rd March 2010 |
|||
7. Threshold(s) that is/are crossed or |
11% |
|||
8. Notified details: |
||||||||||||||||
A: Voting rights attached to shares |
||||||||||||||||
Class/type of
|
Situation previous |
Resulting situation after the triggering transaction |
||||||||||||||
Number |
Number |
Number |
Number of voting |
% of voting rights |
||||||||||||
Direct |
Direct |
Indirect |
Direct |
Indirect |
||||||||||||
GB0059337583 |
12,821,111
|
12,821,111
|
14,003,111
|
|
14,003,111 |
|
11.034% |
|||||||||
|
||||||||||||||||
|
||||||||||||||||
B: Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Expiration |
Exercise/ |
Number of voting |
% of voting |
||||||||||||
- |
- |
- |
- |
- |
||||||||||||
|
||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments |
||||||||||||||||
Resulting situation after the triggering transaction |
||||||||||||||||
Type of financial |
Exercise price |
Expiration date |
Exercise/ |
Number of voting rights instrument refers to
|
% of voting rights
|
|||||||||||
- |
- |
- |
- |
- |
Nominal |
Delta |
||||||||||
- |
- |
|||||||||||||||
|
||||||||||||||||
Total (A+B+C) |
||||||||||||||||
Number of voting rights |
Percentage of voting rights |
|||||||||||||||
14,003,111
|
11.034% |
|||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or the |
||
n/a |
||
|
||
Proxy Voting: |
||
10. Name of the proxy holder: |
n/a |
|
11. Number of voting rights proxy holder will cease |
n/a |
|
12. Date on which proxy holder will cease to hold |
n/a |
|
|
||
|
All figures are based on the Company's issued share capital of 126,914,336 as provided by Exshare
E mail contact RDU@Gartmore.com |
|
14. Contact name: |
RDU |
|
15. Contact telephone number: |
0207 782 2324 |
|
Share Description Fund managing Co. |
Shares held |
% of Issues Share Capital |
UK Registered Owner |
Beneficial Owner |
Equities DELTEX MEDICAL GRP ORD GBP0.01 Gartmore Fund Managers Limited
Gartmore Investment Limited |
6,562,815
1,132,000
6,308,296
|
5.171%
0.892%
4.971% |
HSBC GLOBAL CUSTODY NOMINEE UK LTD
NORTRUST NOMINEES LIMITED VIDACOS NOMINEES LTD A/C 2303 |
GARTMORE FUND MANAGERS LTD A/C GARTMORE UK & IRISH SMALLER COMPANIES
STRATHCLYDE PENSION FUND
THE ALPHAGEN VOLANTIS FUND LIMITED |
|
14,003,111 |
11.034% |
|
|
|
|
|
|
|
|
14,003,111 |
11.034% |
|
|